Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $447.7 million.

  • Neurocrine Biosciences' Retained Earnings rose 143321.92% to $447.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $447.7 million, marking a year-over-year increase of 143321.92%. This contributed to the annual value of $447.7 million for FY2025, which is 143321.92% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Retained Earnings of $447.7 million as of Q4 2025, which was up 143321.92% from $294.0 million recorded in Q3 2025.
  • Over the past 5 years, Neurocrine Biosciences' Retained Earnings peaked at $447.7 million during Q4 2025, and registered a low of -$693.3 million during Q1 2021.
  • Its 4-year average for Retained Earnings is -$168.2 million, with a median of -$113.7 million in 2024.
  • In the last 5 years, Neurocrine Biosciences' Retained Earnings skyrocketed by 3590.63% in 2021 and then skyrocketed by 143321.92% in 2025.
  • Over the past 4 years, Neurocrine Biosciences' Retained Earnings (Quarter) stood at -$628.5 million in 2021, then soared by 75.0% to -$157.1 million in 2023, then soared by 118.59% to $29.2 million in 2024, then surged by 1433.22% to $447.7 million in 2025.
  • Its Retained Earnings was $447.7 million in Q4 2025, compared to $294.0 million in Q3 2025 and $84.5 million in Q2 2025.